[1]
|
R. W. Melvold and R. P. Sticca, “Basic and Tumor Immunology: A Review,” Surgical Oncology Clinics of North America, Vol. 16, No. 4, 2007, pp. 711-735.
doi:10.1016/j.soc.2007.08.003
|
[2]
|
S. Romagnani, “Th1/Th2 Cells,” Inflammatory Bowel Diseases, Vol. 5, No. 4, 1999, pp. 285-294.
doi:10.1002/ibd.3780050410
|
[3]
|
A. Sharma, M. Rajappa, A. Saxena and M. Sharma, “Cytokine Profile in Indian Women with Cervical Intraepithelial Neoplasia and Cancer Cervix,” International Jour nal of Gynecological Cancer, Vol. 17, No. 4, 2007, pp. 879-885. doi:10.1111/j.1525-1438.2007.00883.x
|
[4]
|
N. Nair, S. Mahajan, R. Chawda, C. Kandaswami, T. C. Shanahan and S. A. Schwartz, “Grape Seed Extract Activates Th1 Cells in Vitro,” Clinical and Diagnostic Laboratory Immunology, Vol. 9, No. 2, 2002, pp. 470-476.
|
[5]
|
V. E. Ooi and F. Liu, “Immunomodulation and Anti Cancer Activity of Polysaccharide-Protein Complexes,” Current Medicinal Chemistry, Vol. 7, No. 7, 2000, pp. 715-729.
|
[6]
|
J. Y. Duan, X. P. Liu and Q. Li, “Research on the Effect of Duchesnea indica (Andr.) Focke,” Pharmacology and Clinics of Chinese Materia Medica, Vol. 14, 1998, p. 28.
|
[7]
|
B. Peng, Q. Chang, L. W. Wang, Q. Hu, Y. Q. Wang, J. T. Tang and X. M. Liu, “Suppression of Human Ovarian SKOV-3 Cancer Cell Growth by Duchesnea Phenolic Fraction Is Associated with Cell Cycle Arrest and Apoptosis,” Gynecologic Oncology, Vol. 180, No. 1, 2008, pp. 173-181. doi:10.1016/j.ygyno.2007.09.016
|
[8]
|
M. Shoemaker, B. Hamilton, S. H. Dairkee, I. Cohen and M. J. Campbell, “In Vitro Anticancer Activity of Twelve Chinese Medicinal Herbs,” Phytotherapy Research, Vol. 19, No. 7, 2005, pp. 649-651. doi:10.1002/ptr.1702
|
[9]
|
B. Peng, Q. Hu, X. M. Liu, L. Wang, Q. Chang, J. Li, J. Tang, N. Wang and Y. Wang, “Duchesnea Phenolic Fraction Inhibits in Vitro and in Vivo Growth of Cervical Cancer through Induction of Apoptosis and Cell Cycle Arrest,” Experimental Biology and Medicine (Maywood), Vol. 234, No. 1, 2009, pp. 74-83.
doi:10.3181/0806-RM-204
|
[10]
|
B. Peng, Q. Hu, L. W. Wang, Y. Q. Wang, Q. Chang, J. T. Tang, X. M. Liu, Y. Chen and H. X. Dang, “Study on Anticancer Function of Phenolic Extract from Duchesnea Indica and Its Immunological Mechanism,” Chinese Phar macological Bulletin, Vol. 23, No. 8, 2007, pp. 1007-1010.
|
[11]
|
R. M. Locksley, N. Killeen and M. J. Lenardo, “The TNF and TNF Receptor Superfamilies: Integrating Mammalian Biology,” Cell, Vol. 104, No. 4, 2001, pp. 487-501.
doi:10.1016/S0092-8674(01)00237-9
|
[12]
|
R. Horssen, T. L. M. Hagen and A. M. M. Eggermont, “TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility,” Oncologist, Vol. 11, No. 4, 2006, pp. 397-408.
doi:10.1634/theoncologist.11-4-397
|
[13]
|
S. Mocellin and D. Nitti, “TNF and Cancer: The Two Sides of the Coin,” Frontiers in Bioscience, Vol. 13, 2008. pp. 2774-2783. doi:10.2741/2884
|
[14]
|
R. K. Bhairavabhotla, V. Verma, H. Tongaonkar, S. Shastri, K. Dinshaw and S. Chiplunkar, “Role of IL-10 in Immune Suppression in Cervical Cancer,” Indian Journal of Biochemistry & Biophysics, Vol. 44, No. 5, 2007, pp. 350-356.
|
[15]
|
S. Mocellin, F. M. Marincola and H. A. Young, “Interleukin-10 and the Immune Response against Cancer: A Counterpoint,” Journal of Leukocyte Biology, Vol. 78, No. 5, 2005, pp. 1043-1051. doi:10.1189/jlb.0705358
|